B

BioPlus Co Ltd
KOSDAQ:099430

Watchlist Manager
BioPlus Co Ltd
KOSDAQ:099430
Watchlist
Price: 7 690 KRW 1.85% Market Closed
Market Cap: 433B KRW
Have any thoughts about
BioPlus Co Ltd?
Write Note

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
BioPlus Co Ltd

Revenue
53.5B KRW
Cost of Revenue
-22.1B KRW
Gross Profit
31.4B KRW
Operating Expenses
-15.3B KRW
Operating Income
16.1B KRW
Other Expenses
1.7B KRW
Net Income
17.8B KRW

Margins Comparison
BioPlus Co Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
KR
BioPlus Co Ltd
KOSDAQ:099430
433B KRW
59%
30%
33%
JP
Hoya Corp
TSE:7741
6.8T JPY
86%
28%
24%
CH
Alcon AG
SIX:ALC
37.6B CHF
55%
13%
12%
DK
Coloplast A/S
CSE:COLO B
179.6B DKK
68%
27%
19%
US
Align Technology Inc
NASDAQ:ALGN
15.8B USD
70%
17%
11%
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
52B CNY
72%
45%
42%
CA
Bausch + Lomb Corp
NYSE:BLCO
6.3B USD
61%
4%
-8%
KR
HLB Inc
KOSDAQ:028300
9.1T KRW
15%
-245%
-358%
US
Lantheus Holdings Inc
NASDAQ:LNTH
6.2B USD
65%
32%
29%
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.7B USD
47%
12%
9%
UK
ConvaTec Group PLC
LSE:CTEC
4.5B GBP
56%
13%
7%
Country KR
Market Cap 433B KRW
Gross Margin
59%
Operating Margin
30%
Net Margin
33%
Country JP
Market Cap 6.8T JPY
Gross Margin
86%
Operating Margin
28%
Net Margin
24%
Country CH
Market Cap 37.6B CHF
Gross Margin
55%
Operating Margin
13%
Net Margin
12%
Country DK
Market Cap 179.6B DKK
Gross Margin
68%
Operating Margin
27%
Net Margin
19%
Country US
Market Cap 15.8B USD
Gross Margin
70%
Operating Margin
17%
Net Margin
11%
Country CN
Market Cap 52B CNY
Gross Margin
72%
Operating Margin
45%
Net Margin
42%
Country CA
Market Cap 6.3B USD
Gross Margin
61%
Operating Margin
4%
Net Margin
-8%
Country KR
Market Cap 9.1T KRW
Gross Margin
15%
Operating Margin
-245%
Net Margin
-358%
Country US
Market Cap 6.2B USD
Gross Margin
65%
Operating Margin
32%
Net Margin
29%
Country US
Market Cap 5.7B USD
Gross Margin
47%
Operating Margin
12%
Net Margin
9%
Country UK
Market Cap 4.5B GBP
Gross Margin
56%
Operating Margin
13%
Net Margin
7%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
BioPlus Co Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
KR
BioPlus Co Ltd
KOSDAQ:099430
433B KRW
14%
9%
11%
11%
JP
Hoya Corp
TSE:7741
6.8T JPY
20%
16%
22%
28%
CH
Alcon AG
SIX:ALC
37.6B CHF
6%
4%
5%
5%
DK
Coloplast A/S
CSE:COLO B
179.6B DKK
29%
11%
21%
13%
US
Align Technology Inc
NASDAQ:ALGN
15.8B USD
11%
7%
16%
9%
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
52B CNY
25%
23%
27%
36%
CA
Bausch + Lomb Corp
NYSE:BLCO
6.3B USD
-5%
-3%
2%
2%
KR
HLB Inc
KOSDAQ:028300
9.1T KRW
-33%
-22%
-17%
-17%
US
Lantheus Holdings Inc
NASDAQ:LNTH
6.2B USD
46%
24%
36%
35%
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.7B USD
9%
6%
8%
7%
UK
ConvaTec Group PLC
LSE:CTEC
4.5B GBP
9%
4%
9%
7%
Country KR
Market Cap 433B KRW
ROE
14%
ROA
9%
ROCE
11%
ROIC
11%
Country JP
Market Cap 6.8T JPY
ROE
20%
ROA
16%
ROCE
22%
ROIC
28%
Country CH
Market Cap 37.6B CHF
ROE
6%
ROA
4%
ROCE
5%
ROIC
5%
Country DK
Market Cap 179.6B DKK
ROE
29%
ROA
11%
ROCE
21%
ROIC
13%
Country US
Market Cap 15.8B USD
ROE
11%
ROA
7%
ROCE
16%
ROIC
9%
Country CN
Market Cap 52B CNY
ROE
25%
ROA
23%
ROCE
27%
ROIC
36%
Country CA
Market Cap 6.3B USD
ROE
-5%
ROA
-3%
ROCE
2%
ROIC
2%
Country KR
Market Cap 9.1T KRW
ROE
-33%
ROA
-22%
ROCE
-17%
ROIC
-17%
Country US
Market Cap 6.2B USD
ROE
46%
ROA
24%
ROCE
36%
ROIC
35%
Country US
Market Cap 5.7B USD
ROE
9%
ROA
6%
ROCE
8%
ROIC
7%
Country UK
Market Cap 4.5B GBP
ROE
9%
ROA
4%
ROCE
9%
ROIC
7%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More
Back to Top